Blauvelt, A., Paul, C., van de Kerkhof, P., Warren, R., Gottlieb, A., Langley, R., . . . Reich, K. (2020). Long‐term safety of certolizumab pegol in plaque psoriasis: Pooled analysis over 3 years from three phase III, randomized, placebo‐controlled studies. Br J Dermatol.
استشهاد بنمط شيكاغوBlauvelt, A., et al. "Long‐term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis Over 3 Years From Three Phase III, Randomized, Placebo‐controlled Studies." Br J Dermatol 2020.
MLA استشهادBlauvelt, A., et al. "Long‐term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis Over 3 Years From Three Phase III, Randomized, Placebo‐controlled Studies." Br J Dermatol 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.